Review
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 16, 2014; 2(7): 240-249
Published online Jul 16, 2014. doi: 10.12998/wjcc.v2.i7.240
Infectious burden and atherosclerosis: A clinical issue
Rosa Sessa, Marisa Di Pietro, Simone Filardo, Ombretta Turriziani
Rosa Sessa, Marisa Di Pietro, Simone Filardo, Department of Public Health and Infectious Diseases, “Sapienza” University, 00185 Rome, Italy
Ombretta Turriziani, Department of Molecular Medicine, “Sapienza” University, 00185 Rome, Italy
Author contributions: Sessa R, Di Pietro M, Filardo S and Turriziani O contributed to this paper; all authors read and approved the final version of the manuscript before submission.
Supported by Grants to R. Sessa from Center for Social Disease Research, “Sapienza” University, Rome
Correspondence to: Rosa Sessa, PhD, Department of Public Health and Infectious Diseases, “Sapienza” University, P.le Aldo Moro 5, 00185 Rome, Italy. rosa.sessa@uniroma1.it
Telephone: +39-064-9914102 Fax: +39-064-9914634
Received: December 27, 2013
Revised: May 16, 2014
Accepted: June 10, 2014
Published online: July 16, 2014
Processing time: 205 Days and 1.6 Hours
Abstract

Atherosclerotic cardiovascular diseases, chronic inflammatory diseases of multifactorial etiology, are the leading cause of death worldwide. In the last decade, more infectious agents, labeled as “infectious burden”, rather than any single pathogen, have been showed to contribute to the development of atherosclerosis through different mechanisms. Some microorganisms, such as Chlamydia pneumoniae (C. pneumoniae), human cytomegalovirus, etc. may act directly on the arterial wall contributing to endothelial dysfunction, foam cell formation, smooth muscle cell proliferation, platelet aggregation as well as cytokine, reactive oxygen specie, growth factor, and cellular adhesion molecule production. Others, such as Helicobacter pylori (H. pylori), influenza virus, etc. may induce a systemic inflammation which in turn may damage the vascular wall (e.g., by cytokines and proteases). Moreover, another indirect mechanism by which some infectious agents (such as H. pylori, C. pneumoniae, periodontal pathogens, etc.) may play a role in the pathogenesis of atherosclerosis is molecular mimicry. Given the complexity of the mechanisms by which each microorganism may contribute to atherosclerosis, defining the interplay of more infectious agents is far more difficult because the pro-atherogenic effect of each pathogen might be amplified. Clearly, continued research and a greater awareness will be helpful to improve our knowledge on the complex interaction between the infectious burden and atherosclerosis.

Keywords: Infectious burden; Atherosclerosis; Bacteria; Virus; Pathogenetic mechanisms

Core tip: Several studies support the hypothesis that the infectious burden (IB) may be more involved in the pathogenesis of atherosclerosis than any single pathogen. However, because of the complexity of the interplay of more infectious agents in the host and the limitations of the methods available for the assessment of IB, the role of IB in the pathogenesis of atherosclerosis may have been underestimated.